FINHUB Insights

IEX · Q3 FY25 · Jul 1 – Sep 30, 2025

IDEX Q3 FY25: where the revenue came from and where it went

IDEX Q3 FY25: revenue $0.9B (+10% year over year). Net profit $0.1B. Largest cohort Health and Science Technologies $0.4B. The whole income statement as a sankey diagram from the SEC filing.

Period
Jul 1 – Sep 30, 2025
Reported
Oct 29, 2025 10-Q
Sankey diagram of IDEX's income statement for Q3 FY25: revenue of $0.9 billion splits into segments and flows out into costs, taxes and net profit.

Tap the diagram to enlarge · figures in billions of dollars

Revenue$0.9B +10% year over year
Gross profit$0.4B 44% margin
Operating profit$0.2B 21% margin
Net profit$0.1B 15% margin

The numbers

All figures in billions of U.S. dollars, for Q3 FY25 (period ends Sep 30, 2025).
ItemValueShare of revenueYear over year
Revenue 0.9 100% +10%
Health and Science Technologies 0.4 44% +23%
Fluid and Metering Technologies 0.3 33% +5%
Fire and Safety Diversified… 0.2 22% −3%
Cost of revenue−0.556%
Gross profit0.444% margin+0pp
SG&A−0.223%+0pp
Operating profit0.221% margin+0pp
Net profit0.115%+0pp
Filing on EDGAR More quarters of IEX

Source of the numbers: structured XBRL data from the filing (10-Q). The diagram is generated automatically and checked against EDGAR before release. How we calculate it → About and methodology.

Older quarters